title: Biomarkers in Cardiology - Part 2: In Coronary Heart Disease, Valve Disease and Special Situations.
abstract: Cardiovascular diseases are the main causes of mortality and morbidity in Brazil. Their primary and secondary preventions are a priority for the health system and require multiple approaches for increased effectiveness. Biomarkers are tools used to identify with greater accuracy high-risk individuals, establish a faster diagnosis, guide treatment, and determine prognosis. This review aims to highlight the importance of biomarkers in clinical cardiology practice and raise relevant points regarding their application and perspectives for the next few years. This document was divided into two parts. This second part addresses the application of biomarkers in coronary heart disease, valvular diseases, cardio-oncology, pulmonary embolism, and cardiorenal syndrome.
mesh_terms: D015415:Biomarkers; D002097:C-Reactive Protein / Q000032:analysis; D003327:Coronary Disease / Q000175:diagnosis*; D003935:Diagnostic Techniques, Cardiovascular; D006349:Heart Valve Diseases / Q000175:diagnosis*; D006801:Humans; D020097:Natriuretic Peptide, Brain / Q000097:blood; D010446:Peptide Fragments / Q000097:blood; D011655:Pulmonary Embolism / Q000097:blood; D012307:Risk Factors; D014336:Troponin / Q000097:blood
chemical_list: D015415:Biomarkers; D010446:Peptide Fragments; D014336:Troponin; C109794:pro-brain natriuretic peptide (1-76); D020097:Natriuretic Peptide, Brain; D002097:C-Reactive Protein